Jon Townend News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The University of Birmingham and Acticor Biotech Announce the First Patient Treated in LIBERATE, First Clinical Trial Evaluating Glenzocimab for Heart Attacks

The University of Birmingham and Acticor Biotech Announce the First Patient Treated in LIBERATE, First Clinical Trial Evaluating Glenzocimab for Heart Attacks
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

West midlandsUnited kingdom generalUnited kingdomJon townendNewton biocapitalAdeline meilhocStefan klotterTim mayoMark thomasUniversity hospitals birminghamCardiovascular research unit at northernConsultant cardiologist at university hospitals birminghamInstitute of cardiovascular sciencesEuropean medicines agencyFrench national institute of healthVenture investment

The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack

The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomWest midlandsUnited kingdom generalMark thomasJon townendTim mayoNewton biocapitalAdeline meilhocUniversity of birminghamCardiovascular research unit at northernUniversity hospitals birminghamBirmingham health partnersVenture investmentInstitute of cardiovascular sciencesEuropean medicines agencyMidlands academic health science network

The University of Birmingham and Acticor Biotech announce

University of Birmingham and Acticor Biotech News ReleaseLimited clinical access available The University of Birmingham and Acticor Biotech announce.

West midlandsUnited kingdom generalUnited kingdomTim mayoAdeline meilhocMark thomasNewton biocapitalJon townendMidlands academic health science networkUniversity of birminghamBirmingham health partnersVenture investmentUniversity of sheffieldEuropean medicines agencyFrench national institute of healthInstitute of cardiovascular sciences

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

United kingdomJon townendMark thomasLily ramseyUniversity of birminghamConsultant cardiologist at university hospitals birminghamInstitute of cardiovascular sciencesActicor biotechQueen elizabeth hospitalNorthern general hospitalAssociate professorHonorary consultant cardiologistConsultant cardiologistUniversity hospitals birminghamHonorary professorCardiovascular sciences

Acticor Biotech: The UK Regulatory Agency (MHRA) Approved the Protocol of LIBERATE Study, the First Clinical Trial Evaluating Glenzocimab for Heart Attacks

Acticor Biotech: The UK Regulatory Agency (MHRA) Approved the Protocol of LIBERATE Study, the First Clinical Trial Evaluating Glenzocimab for Heart Attacks
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergUnited kingdomWest midlandsUnited kingdom generalJon townendNewton biocapitalMark thomasYannick pletanTim mayoFrench national institute of healthBirmingham health partnersInstitute of cardiovascular sciencesConsultant cardiologist at university hospitals birminghamUniversity of birminghamMidlands academic health science networkVenture investment